Rising Pharma Holding, Inc. – FDA Inspection, Nov 3, 2023

Record Details

This FDA Inspection record concerns Rising Pharma Holding, Inc., with an inspection on November 3, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Rising Pharma Holding, Inc.
Inspection Date: November 3, 2023
Product Type: Drugs
Office: Center for Drug Evaluation and Research
People: Mayar M. Mussa (Investigator)
Michael Serrano (Company Rep)

View Company Profile

ID · e272947f-5802-444c-bcab-7fcc8235e9bb

Inspection Facts

No Action Indicated (NAI)

No objectionable conditions or practices were found during the inspection.

Inspection number: 1223241
FDA center: Human Drugs
Project area: Bioresearch Monitoring

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Rising Pharma Holding, Inc.

FDA Inspection

Rising Pharma Holding, Inc.November 3, 2023